Concepedia

Sara Durland-Busbice

SD

Statistics

Publications

2

Citations

111

H-Index

2

Active since

2013

Affiliations

Florida Cancer Specialists & Research Institute(Current)

Sara Durland-Busbice is an author at Florida Cancer Specialists & Research Institute specializing in pharmacology, medicine, and oncology.

Publications per year

2013–2022

2

Publications

2

Human Carboxylesterase-2 Hydrolyzes the Prodrug of Gemcitabine (LY2334737) and Confers Prodrug Sensitivity to Cancer Cells

Susan E. Pratt, Sara Durland-Busbice, Robert L. Shepard et al. · Clinical Cancer Research · 2013 · 100 citations

, , +15

A phase Ia/Ib, dose-escalation/expansion study of the MDM2–p53 antagonist BI 907828 in patients with solid tumors, including advanced/metastatic liposarcoma (LPS).

Mrinal M. Gounder, Noboru Yamamoto, Manish R. Patel et al. · Journal of Clinical Oncology · 2022 · 11 citations · Full text

, , +10

1–2 of 2